Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

New ANDA Review Pathways: Should You Be A Priority Or Expedited?

priority button

Related Content

More ANDAs To Be Eligible For Priority Review, Gottlieb Says

Nov 08 2017

ANDA Sponsors Get Wide-Open Facility Deadline For Priority Review

Aug 23 2017

Breakthrough-Style Program For ANDAs Added To House User Fee Bill

May 19 2017

Generic Priority Review Expanded In Senate User Fee Bill

May 12 2017

“Breakthrough” Designation: FDA Clarifies How To Get It – And How It Can Be Lost

May 29 2014

Related Companies

Teva Pharmaceutical Industries Ltd.

Additional Topics

United States Generic Drugs Review Pathway Regulation FDA BioPharmaceutical

More from Generics

More from Biosimilars & Generics

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window